Cargando…

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study

Clinical trials have shown the benefits of β-blockers therapy in patients with heart failure reduced ejection fraction. These benefits include improved survival and a reduced need for hospitalization. Cardiac resynchronization therapy has emerged as an essential device-based therapy for symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masarone, Daniele, Verrengia, Marina, Ammendola, Ernesto, Gravino, Rita, Valente, Fabio, Vastarella, Rossella, Rubino, Marta, Limongelli, Giuseppe, Pacileo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630463/ https://www.ncbi.nlm.nih.gov/pubmed/31216616 http://dx.doi.org/10.3390/medsci7060071

Ejemplares similares

Effects of Sacubitril/Valsartan on the Right Ventricular Arterial Coupling in Patients with Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2020)

Management of Arrhythmias in Heart Failure
por: Masarone, Daniele, et al.
Publicado: (2017)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
por: Masarone, Daniele, et al.
Publicado: (2018)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
por: Falco, Luigi, et al.
Publicado: (2023)

Berlin Heart EXCOR® pediatric ventricular assist device in a patient with Sotos syndrome: a case report
por: Gravino, Rita, et al.
Publicado: (2019)

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease
por: Limongelli, Giuseppe, et al.
Publicado: (2018)

Left Ventricular Assist Device Implantation in a Thrombosed Apical Aneurysm
por: Masarone, Daniele, et al.
Publicado: (2021)

Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy
por: Limongelli, Giuseppe, et al.
Publicado: (2019)

The Role of Echocardiography in the Management of Heart Transplant Recipients
por: Masarone, Daniele, et al.
Publicado: (2021)

Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study
por: Masarone, Daniele, et al.
Publicado: (2022)

Pathophysiology-Based Management of Acute Heart Failure
por: Falco, Luigi, et al.
Publicado: (2023)

The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2022)

Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
por: Waranugraha, Yoga, et al.
Publicado: (2021)

Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report
por: Masarone, Daniele, et al.
Publicado: (2022)

A common polymorphism in the SCN5A gene is associated with dilated cardiomyopathy
por: Mazzaccara, Cristina, et al.
Publicado: (2018)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice
por: Masarone, Daniele, et al.
Publicado: (2023)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction
por: Park, Chan Soon, et al.
Publicado: (2022)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Contrast‐induced nephropathy after cardiac resynchronization therapy implant impairs the recovery of ejection fraction in responders
por: Strisciuglio, Teresa, et al.
Publicado: (2019)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients
por: Russo, Vincenzo, et al.
Publicado: (2022)

Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy
por: Zhang, Nixiao, et al.
Publicado: (2020)

Evaluation of potential underuse of cardiac resynchronization therapy for heart failure with reduced ejection fraction
por: Takano, Makoto, et al.
Publicado: (2021)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers
por: Cattadori, Gaia, et al.
Publicado: (2020)

Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
por: Turgeon, Ricky D., et al.
Publicado: (2019)

Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction
por: Luzum, Jasmine A., et al.
Publicado: (2023)

Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2023)

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
por: Schurtz, Guillaume, et al.
Publicado: (2023)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real‐world study
por: Wang, Chen, et al.
Publicado: (2023)

Curative effect of β-blocker on various ejection fractions of patients with atrial fibrillation
por: Cao, Wei, et al.
Publicado: (2019)

Use of Cardiac Contractility Modulation in an Older Patient with Non-Ischemic Dilated Cardiomyopathy: A Case Report
por: Manganelli, Gianvito, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jhocv67v63b4pn5rtn1oaa8qo2